Health economics and outcomes research
Health economics and outcomes research
We combine proven methods with innovative, customized solutions to help pharmaceutical, biotech, and medical device clients generate robust HEOR evidence.
Solutions across every stage of product development and commercialisation
Solutions across every stage of product development and commercialisation
- Efficacy, safety, costs, economic evaluations, clinical outcome assessments (COAs), and health-related quality of life (HrQoL) utilities.
- Selection, design, development, and validation of COAs, refinement of endpoint selections, and preparation of COA dossiers for regulatory submissions.
- Assessment and data analysis for equivalent testing of COAs migrated to electronic platforms.
- De novo global economic models for HTA/reimbursement, including survival analysis and local country adaptations.
- Discrete choice experiments, design and evaluation of patient support programs, and utility data generation for economic modeling and HTA submissions.
- Formal and informal guidance on evidence generation for HTA/reimbursement, briefing book preparation, scientific advice meeting support, and HTA dossier development.
- Creation of global value dossiers, payer engagement slide decks, objection handlers, and toolkits to convey product benefits.